Headline Post

9 articles this week

Latest

Top 3 SPAC Targets – Late-Stage Biotech

Biotech is big in the world of SPACs once again. Half of the SPACs that have managed to IPO in the second half of October are specifically targeting the industry and three biotech deals have been announced since the start of the month. More

Nicholas Alan Clayton·Oct 29

Morning SPAC News Roundup: October 29, 2026

Another SPAC has made it through the IPO slowdown, but its team has once again made some considerable concessions to get it done. In the case of BHAV II (NASDAQ:BHAIU), the sponsor only overfunded its trust to 100. More

Nicholas Alan Clayton·Oct 29

BHAV Acquisition Corp. II (BHAIU) Prices $100M IPO

BHAV Acquisition Corp. II (NASDAQ:BHAIU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "BHAIU" on Thursday, October 29, 2026. More

Nicholas Alan Clayton·Oct 28

Podcast: Agility and Churchill Capital XI (CCXI) Chart a Path for Humanoid Robotics

This week, we speak with Michael Beer, CFO of Agility Robotics, and Daniel Diez, Chief Business Officer of the company. Together, we discuss Agility’s $2.5 billion business combination with Churchill Capital Corp. More

Kristi Marvin·Oct 28

New SPAC: Heroic Empire Acquisition Limited Files for $100M IPO

Heroic Empire has filed for a $100 million IPO in what is the first new SPAC S-1 to hit the SEC in two weeks. Well, "new" is perhaps a misnomer in this case, as the team previously filed to IPO a SPAC under the same name back in 2022. More

Nicholas Alan Clayton·Oct 27

SPACCircle Acquisition Corp. (SCQCU) Prices $100M IPO

SPACCircle Acquisition Corp. (NASDAQ:SCQCU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol "SCQCU" on Tuesday, October 27, 2026. More

Nicholas Alan Clayton·Oct 26

Amanat (AMAN) to Combine with Corxel US in $228M Deal

Amanat (NASDAQ:AMAN) has entered into a definitive agreement to combine with biotech firm Corxel Pharmaceuticals at an enterprise value of $228 million. Corxel is developing an oral GLP-1 weight-loss drug as well as other potential treatments. More

Nicholas Alan Clayton·Oct 26

Morning SPAC News Roundup: October 26, 2026

With just one week left in October, the month has currently represented a slowdown in SPAC IPOs, with just four teams pricing their vehicles since October 1. More

Nicholas Alan Clayton·Oct 26

SPAC IPO Terms Tracker: October 23, 2026

Terms Tracker for the Week Ending October 23, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. It was a very quiet week with zero SPAC IPOs priced and zero new SPACs filed, but there were two new deals announced to bring the year-to-date announcement count to 85. More

Kristi Marvin·Oct 24

APEX Tech (TRAD) to Combine with Korai Flix in $3.5Bn Deal

APEX Tech (NYSE:TRAD) has entered into a definitive agreement to combine with South Korean film studio Korai Flix at a $3.5 billion pre-money equity value. Korai Flix has launched an online content platform that provides AI-generated short films and allows users to produce their own interactive content with AI avatars. More

Nicholas Alan Clayton·Oct 21